Skip to main content
. 2020 Dec 2;406(4):1165–1172. doi: 10.1007/s00423-020-02038-z

Table 1.

Characteristics of the included patients

Segmental colectomy Subtotal colectomy Proctocolectomy Proctectomy p
Patients 30 55 12 25
M:F 14:16 23:32 7:5 12:13 0.761
Age 47 (28–79) 39 (17–83) 50 (24–76) 47 (22–77) 0.163
BMI 22 (16–27) 21 (14–30) 24 (15.4–30) 24.5 (18–38) 0.006
Recurrent disease 15 (50%) 24 (43.6%) 8 (66.6%) 20 (80%) 0.017
Montreal classification A

A1 11 (36.7%)

A2 12 (40%)

A3 7 (23.3%)

A1 11 (20%)

A2 27 (49.1%)

A3 17 (30.9%)

A1 2 (16.6%)

A2 2 (16.6%)

A3 8 (66.6%)

A1 1 (4%)

A2 8 (8%)

A3 14 (56%)

0.009
Montreal classification L

L2 19 (63.3%)

L3 11 (36.7%)

L2 30 (54.5%)

L3 25 (45.5%)

L2 4 (33.3%)

L3 8 (66.6%)

L2 17(68%)

L3 8 (32%)

0.136
Montreal classification B

B1 3 (10%)

B2 18 (60%)

B3 9 (30%)

B1 17 (30.9%)

B2 25 (45.5%)

B3 13 (23.6%)

B1 3 (25%)

B2 5 (41.7%)

B3 4 (33.3%)

B1 10 (40%)

B2 7 (28%)

B3 8 (32%)

0.429
Perianal disease 16 (53.3%) 23 (41.8%) 8 (66.6%) 18 (72%) 0.231
Previous abdominal surgery 16 (53.3%) 29 (52.7%) 6 (50%) 24 (96%) 0.001
MDT 23 (76.6%) 33 (60%) 8 (66.6%) 12 (48%) 0.169
USS 17 (56.6%) 29 (52.7%) 4 (33.3%) 8 (32%) 0.173
MRI 21 (70%) 35 (63.6%) 7 (58.3%) 19 (76%) 0.538
CT 24 (80%) 23 (41.8%) 7 (58.3%) 8 (32%) <0.001
Capsule 0 1 (1.8%) 0 0 0.746
Stoma nurse 15 (50%) 22 (40%) 6 (50%) 9 (36%) 0.674
Dietitian 15 (50%) 17 (30.9%) 2 (16.6%) 2 (8%) 0.042
TPN 7 (23.3%) 8 (14.5%) 2 (16.6%) 2 (8%) 0.433
Steroids 11 (36.6%) 27 (49.1%) 4 (33.3%) 4 (16%) 0.043
Immunosupp 3 (10%) 7 (12.7%) 2 (16.6%) 2 (8%) 0.858
Anti-TNF 9 (30%) 16 (29.1%) 0 1 (4%) 0.010

M male, F female, BMI body mass index, Montreal classification A age at diagnosis, L location, B phenotype, MDT multidisciplinary team; USS ultrasound, MRI magnetic resonance imaging, CT computed tomography, TPN total parenteral nutrition, TNF tumor necrosis factor

p values are from Pearson’s chi square and from one-way ANOVA

HHS Vulnerability Disclosure